Drawing for STRATACOR

USPTO serial 86839214

STRATACOR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STRATACOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ruth Rivard

Ruth Rivard Stinson Leonard Street LLP150 South 5th Street, Ste 2300Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemicals for use in industry and science, and chemicals for use in the manufacture of cosmetics, pharmaceuticals, medical devices; Chemical ingredients for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for treating wounds, treating infectious disease, and chemical additives for use as cleansing, deodorizing and refreshing ingredients in the manufacture of mouth sprays, dental cements and medicines for dental purpose; Adhesives for use in the medical, dental, vision, health, healthcare, veterinary, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, adhesives for use in industry and adhesives other than for stationery or household purposes; Antioxidants, namely, antioxidants for use in the manufacture of a wide variety of goods; Proteins, namely, proteins for use in the manufacture of a wide variety of goods; Protein arrays and nucleotide arrays for scientific and medical research; Protein for industrial use; Protein in raw material form for scientific and medical research; Biochemicals, namely, biochemical catalysts, biochemical reagents used for non-medical purposes, biochemical for in vitro and in vivo scientific use, and chemicals for use in the biochemical and chemical industry; Biological tissue for laboratory, research, clinical or medical laboratory use, namely, biological tissue cultures other than for medical or veterinary purposes, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; Cells for laboratory, research, clinical or medical laboratory use; Ceramic compositions for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, ceramic compositions in the solid state for manufacture of fibrous monolithic ceramic compartments for use in high temperature applications; Chemical agents for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical agents for chelating and sequestering, and chemical agents for removing acid in industrial manufacturing application; Chemical compounds for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical compositions for solidification of fluids, metal plating chemical compositions, and waterproofing chemical compositions; Chemical preparations for use in the medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical preparations for use in industry, chemical preparations for use in medical device industry, chemical preparations for scientific purposes, chemical additives for use in the manufacture of cosmetics and pharmaceuticals; Chemical products for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical agents for chelating and sequestering, chemical agents for removing acid in industrial manufacturing applications, chemical products for preventing scale, and chemical products for stabilizing foodstuffs; Chemical reagents for laboratory, research, clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic reagents for laboratory, research, clinical or medical laboratory use; Enzymes for industrial purposes; enzymes for scientific and research purposes; Minerals for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, mineral substances in the nature of sorbents, sulphur, huntite used in industry, hydromagnesite used in industry, and mineral substances used to oxidize impurities and regulate temperatures in glass production furnaces; Metals for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, alkaline metals, and rare earth metals; Plant and herb extracts for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, plant and herb extracts for use in the manufacture of creams, lotions and cosmetic products; Plastics for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, protein plastics, unprocessed plastics in all forms; Polymers, namely, unprocessed polymers, acrylic polymer powders, polymer beads for use in manufacturing, and polymer compositions used in the manufacture of commercial and industrial goods; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical, dental, and vision devices, cosmetics, personal care products, coatings, adhesives, and lubricants; Stem cells other than for medical or veterinary use; Resins, namely, unprocessed artificial and synthetic resins for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields; Biological tissue, namely, SHED stem cells (stem cells from human exfoliated deciduous teeth), dental pulp and human maxiofacial bone elements for scientific use and research in cellular healing therapies; Chemical additives for use as cleansing, deodorizing and refreshing ingredients in the manufacture of mouth sprays, dental cements and medicines for dental purposes; Diagnostic preparations for clinical or medical laboratory useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 28, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 28, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 24, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 20, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 29, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 29, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 9, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 21, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2016DOCKASSIGNED TO EXAMINER—
Dec 10, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Dec 9, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 8, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance